Steven
Marshank is a private consultant who has collaborated with several stem cell
companies around the world. Beike Biotechnology and SiriCell Technologies are
both Oregon biotechnology companies that are working to develop cutting-edge
treatments for chronic conditions, genetic disorders, and other major health
problems. Steven’s consulting firm, Marshank Consulting, specializes in giving
expert advice to companies that are on the cutting edge in adult stem cell
research. Steven Marshank has studied stem cells and biotechnology for more
than five years. He has numerous professional certifications and more than 40
years of experience as a private consultant with Marshank Consulting.
Beike
Biotechnology focuses on using stem cell research and technologies to cure
disease. The company is based in China, but works around the world. It works on
translating information from stem cell research into clinical practice and on
developing technologies to support the use of breakthroughs from stem cell
research. SiriCell Technologies works in experimental adult stem cell therapies
towards treating, curing, and rehabilitating patients from serious health
problems. SiriCell has been a leader in research, development of
biotechnologies, and biotechnology commerce since it was founded in 2008.
Steven Marshank served as Director of International Development at SiriCell
Technologies from June 2007 through November 2011. He also served as Director
of International Development at Beike Biotechnologies from August 2007 to
October 2010. In his nearly five years as Director of International Development
for these two companies, Steven Marshank helped them build international name
recognition, contacts, and business. He increased international revenue for
both companies. More importantly, Steven Marshank helped bring the cutting-edge
health research done by Beike Biotechnology and SiriCell Technologies to health
researchers around the world. As Director of International Development, he also
forged partnerships that will improve stem cell research by merging the
capacities of Beike Biotechnology, SiriCell Technologies, and their
international partners.
No comments:
Post a Comment